Treuhaft, P
The SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in people with obesity and established cardiovascular disease
Yatham LN, Schaffer A, Kessing LV, Miskowiak K, Kapczinski F, Vieta E, et al
In these, the described BPC 157 efficacy is considered as an important demonstration of the confirmation that BPC 157 could ensure a particular specificity within the Egr, Nos, Srf, Vegfr, Akt1, Plc , and Kras pathways (Vukojevic et al., 2018)
They can help with formulation problems, regulation questions, and special synthesis needs that can't be met by regular catalog items
Age 20: ~200 ng/mL Age 60: ~80 ng/mL (around a 60% decline) That drop helps explain why GHK-Cu keeps getting framed as a restoration peptide